Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Treasury Shares: 2023-2025

Historic Treasury Shares for Artiva Biotherapeutics (ARTV) over the last 1 years, with Sep 2025 value amounting to $1.3 million.

  • Artiva Biotherapeutics' Treasury Shares was N/A to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $506,845 for FY2024, which is 2151.24% up from last year.
  • Artiva Biotherapeutics' Treasury Shares amounted to $1.3 million in Q3 2025, which was down 7.17% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Treasury Shares registered a high of $1.5 million during Q1 2025, and its lowest value of $22,514 during Q4 2023.
  • For the 3-year period, Artiva Biotherapeutics' Treasury Shares averaged around $957,810, with its median value being $1.3 million (2025).
  • Data for Artiva Biotherapeutics' Treasury Shares shows a peak YoY skyrocketed of 2,151.24% (in 2024) over the last 5 years.
  • Over the past 3 years, Artiva Biotherapeutics' Treasury Shares (Quarterly) stood at $22,514 in 2023, then surged by 2,151.24% to $506,845 in 2024, then reached $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.4 million for Q2 2025, and $1.5 million during Q1 2025.